Neuron-released oligomeric α-synuclein is an endogenous agonist of TLR2 for paracrine activation of microglia

Kim, Changyoun, Ho, Dong-Hwan, Suk, Ji-Eun, You, Sungyong, Michael, Sarah, Kang, Junghee, Joong Lee, Sung, Masliah, Eliezer, Hwang, Daehee, Lee, He-Jin, Lee, Seung-Jae·2013·Nature Communications
DOI 10.1038/ncomms2534

Cited by (863)

Items 701–800 of 863

  1. Alpha-Synucleinopathies
    C. H. Camargo, Marcus Vinicius Della-Coletta, Delson José da Silva, H. Teive · 2019 · Advances in Medical Diagnosis, Treatment, and Care
  2. Molecular Basis of Neurodegeneration: Lessons from Alzheimer’s and Parkinson’s Diseases
    Juan Manuel Zolezzi, Sussy Bastias Candia, Nibaldo C. Inestrosa · 2019 · IntechOpen eBooks
  3. Autophagy in DG engrams mediates Rac1-dependent forgetting via TLR2/4 signals in microglia
    Zhilin Wang, Ruyan Chen, Qing Lin, Yan Jiang, Qiumin Le, Xing Liu, Lan Ma, Feifei Wang · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  4. CD13 Activation Assembles Signaling Complexes that Promote the Formation of Tunneling Nanotubes in Endothelial Cells
    Emily K. Meredith, Brian Aguilera, Fraser McGurk, Pengyu Zong, Lixia Yue, Mallika Ghosh, Linda H. Shapiro · 2024 · bioRxiv (Cold Spring Harbor Laboratory)
  5. Rehabilitation for non-motor symptoms for patients with Parkinson’s disease from an α-synuclein perspective: a narrative review
    Zhaoyang Liu, Jessica Lemus, Irina V. Smirnova, Wen Liu · 2023 · Exploration of Neuroprotective Therapy
  6. Toll-like receptors as a missing link in Notch signaling cascade during neurodevelopment
    Mario Stojanovic, Svjetlana Kalanj Bognar · 2024 · Frontiers in Molecular Neuroscience
  7. Tan I modulates astrocyte inflammatory responses through enhanced NAD+–Sirt1 pathway: Insights from metabolomics studies
    Fenglun Zhao, Jia-Rui Zhang, Man-Hua Liu, Huiyi Liu, Cheng-Jie Mao, Fen Wang, Juping Chen, Chun-Feng Liu · 2025 · International Immunopharmacology
  8. Exploring LRRK2-dependent Mechanisms in Parkinson’s Disease Therapy
    Veerta Sharma, Shiwali Sharma, Shareen Singh, Thakur Gurjeet Singh · 2025 · CNS & Neurological Disorders - Drug Targets
  9. Molecular mechanisms of exercise-induced neuroprotection against Parkinson's disease
    Youngil Lee, Beomsoo Ju, Yohan Cheon, Namita Mishra, Emma Fletcher, Panagiotis Koutakis, Gulnaz T. Javan, Young Charles Jang · 2025 · Sports Medicine and Health Science
  10. The multifaceted role of antimicrobial peptides in neurodegeneration: Insights from Drosophila and beyond
    Priyatama Behera, Nagaraj Rangappa, Madhura Chandrashekar, Amit Mishra, Subashchandrabose Chinnathambi, Monalisa Mishra · 2025 · Advances in protein chemistry and structural biology
  11. Deficiency of Toll-like receptor 2 is a driver of sex-related compositional and structural rearrangements of membrane lipids
    Raluca Ică, Kristina Mlinac, Mario Stojanović, Maria Roxana Biricioiu, Borna Puljko, Nikolina Maček Hrvat, Marina Dobrivojević Radmilović, Željka Korade, Károly Mirnics, David E. Clemmer et al. · 2025 · Communications Chemistry
  12. Cellular prion protein and calcium ions trigger the neurotoxicity of α-synuclein aggregates
    Alessandra Bigi, Andrea Carlotta Conti, Liliana Napolitano, Giuliana Fusco, Alfonso De Simone, Fabrizio Chiti, Roberta Cascella, Cristina Cecchi · 2025 · Cell & Bioscience
  13. Akkermansia muciniphila: A double-edged sword in life-stage-specific nutritional modulation of Parkinson’s disease via the gut-brain axis
    Nan Chen, Dejiang Pang, Huifang Shang · 2025 · Microbiological Research
  14. Glutamate-Glutamine metabolism and transport, implications in Parkinson’s disease
    Ragini Raghu, Subashchandrabose Chinnathambi · 2026 · International review of neurobiology
  15. iPSC-derived microglia: Decoding roles and therapeutic opportunities in neurodegenerative diseases
    Didi Shan, Hongxu Wang, Jianing Li, Yao Tang, Zexin Zhan, Chuanzhu Yan, Jingwen Xu, Fuchen Liu · 2026 · Brain Research Bulletin
  16. CCL2 and PAK6 as Candidate Biomarkers of Neuroinflammation in Parkinson’s Disease: An Integrated Machine Learning and Single-Nucleus Transcriptomic Study
    Qixin Zhu, Zhen Zhang, Leiming Zhang, Qi Li, T Zhang, Fei Yang · 2026 · Brain Sciences
  17. Efferocytosis: Signaling Pathways and New Therapeutic Strategies for Diseases
    Lei Wang, Jingjing Ge, Zehua Wang, Yihua Fang, Yongxu Jia, Ruyue Zhang, Yanru Qin · 2026 · MedComm
  18. Aberrant immunomodulatory signature in β-propeller protein-associated neurodegeneration patient iPSC-derived microglia
    Gamze Özata, Rachel M. Wise, Aida Cardona‐Alberich, Naiyareen Fareeza Mayeen, Stephan A. Müller, Stefan F. Lichtenthaler, Luigi Zecca, Lena F. Burbulla · 2026 · Scientific Reports
  19. The irisin-PINK1/Parkin axis plays an essential role in mediating microglial mitophagy: A crucial mechanism for exercise-induced neuroprotection against Parkinson's disease
    Bin Wang, Xin Liu, Xin Tian, Junjie Lin, Qian Li, Yue Wu, Renqing Zhao · 2026 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
  20. Metabolic and epigenetic regulation of microglia memory in neurological disorders
    Xiaoya Wang, Yunpeng Jia, X Z Yan, Youwei Wang · 2026 · Journal of Leukocyte Biology
  21. Neuroprotective Effects of Distilled Extract of Zanthoxylum piperitum in Parkinson’s Disease Models
    Su Bin Park, Jihoon Kong, Gabsik Yang, Ye-eun Baek, Amjad Khan, Tae Han Yook, Ji Yong Jang, Jong Uk Kim · 2026 · Nutrients
  22. The critical role of microglia in the stress response
    Ke Chen, Zong-yuan Xuan, Bao-yi Sun, Guan-ning Zhong, Xiao-lei Sun, Jun Yan · 2026 · Neuroscience & Biobehavioral Reviews
  23. Inflammation in central nervous system diseases
    Takashi Shichita, Akihiko Yoshimura · 2016 · Clinical and Experimental Neuroimmunology
  24. Changes in the Immune System in Parkinson’s Disease
    Marina Romero‐Ramos · 2017 · Springer eBooks
  25. The role of environmental toxins and inflammation in Parkinson's disease pathophysiology: a historical perspective and research-based evidence
    Francisco J. Pan-Montojo, Kai F. Loewenbrück, Heinz Reichmann · 2020 · Elsevier eBooks
  26. Glial Cells
    Teresa Faria Pais · 2016 · Compendium of Inflammatory Diseases
  27. Microglia-Mediated Neuroinflammation in Parkinson’s Disease
    Vila Bulls · 2023 · Science Insights
  28. Perspective Chapter: The Role of Dopamine Receptors in Neuropsychiatric Diseases
    Burak Yaman · 2023 · IntechOpen eBooks
  29. The Impact of Intestinal Microbiota and Toll-like Receptor 2 Signaling on α-Synuclein Pathology in Nontransgenic Mice Injected with α-Synuclein Preformed Fibrils
    Yukako Koyanagi, Momoe Kassai, Hiroshi Yoneyama C · 2024 · Microorganisms
  30. NEUROINFLAMMATION AND IMMUNE DYSFUNCTION IN THE PATHOGENESIS OF PARKINSON’S DISEASE
    Galina V. Idova, Альперина Елизавета Лазаревна, Svetlana Ya. Zhanaeva · 2023 · Журнал высшей нервной деятельности им И П Павлова
  31. AIMP2 accumulation in brain leads to cognitive deficits and blood secretion in Parkinson’s disease
    Heejeong Kim, Jeong‐Yong Shin, Sangwoo Ham, Ji Hun Kim, Gum Hwa Lee, Nae‐Eung Lee, Hee-Tae Kim, Seok Hyun Cho, Sang Seong Kim, Yunjong Lee · 2024 · Journal of Translational Medicine
  32. Deciphering motor dysfunction and microglial activation in mThy1-α-synuclein mice: a comprehensive study of behavioral, gene expression, and methylation changes
    Brett A. McGregor, Md. Obayed Raihan, Afrina Brishti, Junguk Hur, James E. Porter · 2025 · Frontiers in Molecular Neuroscience
  33. Immune response during idiopathic Parkinson's disease: From humans to animal models
    Sara Konstantin Nissen, Sara Almeida Ferreira, Ida Hyllen Klæstrup, Marina Romero‐Ramos · 2021 · International review of movement disorders
  34. Repositioning doxycycline for treating Parkinson’s disease: Evidence from a pre‐clinical mouse model
    Pietro La Vitola, Luisa Artioli, Milica Cerovic, CristianClaudia PolettoBalducci, Letizia Dacomo, Susanna Leva, Claudia Balducci, Gianluigi Forloni · 2021 · Alzheimer s & Dementia
  35. Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits a mouse model of DLB/PD
    Michiyo Iba, Ross A. McDevitt, Changyoun Kim, Roshni Roy, Dimitra Sarantopoulou, Ella Tommer, Somin Kwon, Byron Siegars, Michelle A. Sallin, Jyoti Misra Sen et al. · 2021 · Research Square
  36. Modelling Parkinson’s Disease Pre-Clinically: A Novel Virus-Fibril Inducible Mouse Model Exploring Disease Characteristics and Therapeutic Intervention via Metabotropic Glutamate Receptor 5 Negative Allosteric Modulation
    Samantha C. Bureau · 2022 · Carleton University's Institutional Repository (MacOdrum Library, Carleton University)
  37. Neurodegeneration and neuroinflammation are linked, but independent of α -synuclein inclusions, in a seeding/spreading mouse model of Parkinson’s disease
    Pierre Garcia, Wiebke M. Wemheuer, Oihane Uriarte Huarte, Kristopher J. Schmit, Annette Masuch, Simone Brioschi, Andreas Weihofen, Eric Koncina, Djalil Coowar, Tony Heurtaux et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  38. MerTK mediates the immunologically silent uptake of alpha-synuclein fibrils by human microglia
    Marie‐France Dorion, Konstantin A. Senkevich, Moein Yaqubi, Nicholas W. Kieran, Carol X.‐Q. Chen, Adam MacDonald, Wen Luo, Amber Wallis, Irina Shlaifer, Jeffery Alan Hall et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  39. Parkinson’s disease-derived α-Synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype
    Cansu Yildirim, Alexis Fenyi, Pierre Besnault, Lina Gomez, Julia Elisa Sepulveda-Diaz, Patrick Pierre Michel, Ronald Melki, Stéphane Hunot · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  40. Defining the mechanisms of microbial sensing among members of the toll-like receptor 2 sub-family
    Diana Rose E. Rañoa · 2014 · Illinois Digital Environment for Access to Learning and Scholarship (University of Illinois at Urbana-Champaign)
  41. Extracellular α-Synuclein as a Target for Immunotherapy
    Jun Sung Lee, Seung‐Jae Lee · 2016 · Methods in pharmacology and toxicology
  42. Ion-Catalyzed Reactive Oxygen Species in Sporadic Models of Parkinson’s Disease
    Velmarini Vasquez, Joy Mitra, Erika N. Guerrero, Pavana M. Hegde, K. S. Jagannatha Rao, Muralidhar L. Hegde · 2016 · Springer eBooks
  43. Parkinson’s Disease and Other Synucleinopathies
    Mark R. Cookson · 2018 · Elsevier eBooks
  44. Design of antioxidant nanotherapeutics for attenuation of atherogenesis and neuroinflammation
    Rebecca Chmielowski · 2018
  45. Lewy Body Dementia and the Role of Inflammation
    Ajenthan Surendranathan · 2018 · Apollo (University of Cambridge)
  46. Insulin resistance and Parkinson’s disease
    A. A. Farooqui · 2020 · Elsevier eBooks
  47. [The role of neuroinflammation-related regulatory targets in the treatment for Parkinson’s disease].
    Caixia Zang, Xiu-qi Bao, Hua Sun, Dan Zhang · 2016 · PubMed
  48. Alpha-synuclein spreading pathology in Parkinson's disease: the influence of iron and the Rho-kinase inhibitor fasudil
    Karina Joppe · 2020 · eDiss (Georg-August-Universität Göttingen)
  49. Mechanism of beta 2 adrenergic receptor (β2AR) agonist in regulation of inflammation in Parkinson’s disease
    Monika, . · 2019 · ERA: Education and Research Archive (University of Alberta)
  50. Neurodegeneration and Neuroinflammation are Linked, but Independent of α-Synuclein Inclusions, in a Seeding/Spreading Mouse Model of Parkinson’s Disease
    Pierre Garcia, Wiebke M. Wemheuer, Oihane Uriarte Huarte, Kristopher J. Schmit, Annette Masuch, Simone Brioschi, Andreas Weihofen, Eric Koncina, Djalil Coowar, Tony Heurtaux et al. · 2020
  51. Molecular mechanisms of neurodegeneration in neurodegenerative diseases
    A. A. Farooqui · 2020 · Elsevier eBooks
  52. MAPK14-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease
    Jialong Chen, Kanmin Mao, Honglin Yu, Yue Wen, Hua She, Liuna Yang, He Zhang, Huihui Li, Xian Wu, Yixian Ren et al. · 2020 · Research Square
  53. Gut microbiota and brain function and pathophysiology
    Asim K. Duttaroy · 2021 · Elsevier eBooks
  54. Mikroglial Toll-benzeri Reseptörlerin Alzheimer ve Parkinson Hastalıklarındaki Rolü
    Dilara Nemutlu Samur, Gül Özbey · 2021 · Akdeniz Medical Journal
  55. Role of Inflammation in Lewy Body Dementia
    Ajenthan Surendranathan, John Tiernan O'Brien · 2021 · Cambridge University Press eBooks
  56. Alpha-synuclein spreading mechanisms in Parkinson's disease: The role of membrane receptors
    Inês Caldeira Brás, Tiago F. Outeiro · 2021 · International review of movement disorders
  57. Changes in the Immune System in Parkinson’s Disease
    Marina Romero‐Ramos · 2019 · Springer eBooks
  58. Expression of transduced Nucleolin promotes the clearance of accumulated alpha-synuclein
    Dong Hwan Ho, Daleum Nam, Soyeon Jeong, Mi Kyoung Seo, Sung Woo Park, Wongi Seol, Ilhong Son · 2020
  59. Methodology of neuronal pluripotent stem cell of in vitro difference process as an alternative therapy of neurodegenerative disease
    Wahyuni Wulansari, Fuad Gandhi Torizal, Annisa Khumaira, Ika Afifah Nugraheni · 2022 · JHeS (Journal of Health Studies)
  60. Glial Cells
    Teresa Faria Pais · 2015 · Encyclopedia of Inflammatory Diseases
  61. Dose-related biphasic effect of the Parkinson’s disease neurotoxin MPTP, on the spread, accumulation, and toxicity of α-synuclein
    M. Emdadul Haque, Madiha Mohieldin Merghani, Mustafa Taleb Ardah, Tohru Kitada · 2020
  62. Alpha-Synucleinopathies
    Carlos Henrique Ferreira Camargo, Marcus Vinícius Della Coletta, Delson José da Silva, Hélio Afonso Ghizoni Teive · 2020 · IGI Global eBooks
  63. Effects of probiotic supplementation on gastrointestinal motility, inflammation, motor and non-motor symptoms in Parkinson's disease: a meta-analysis of randomized controlled trials
    Jong Mi Park, Sang Chul Lee, Chorom Ham, Yong Wook Kim · 2023 · Research Square
  64. Naïve Huntington’s disease microglia mount a normal response to inflammatory stimuli but display impaired development of innate immune tolerance that can be counteracted by ganglioside GM1
    Noam Steinberg, Danny Galleguillos, Asifa K. Zaidi, Simonetta Sipione · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  65. Rapamycin Protects Dopaminergic Neurons by Suppressing Tlr2 Mediated Neuroinflammation and Enhancing Autophagy in Rotenone-Induced Pd Mice
    xifang xie, Songxue Su, Yujiao Huang, Qunli Cui, Weidong Zang · 2023 · Research Square
  66. Novel Theranostics for Parkinson's Disease
    Benjamin William Schlichtmann · 2021
  67. Additional file 2 of PI3K-AKT activation resculpts integrin signaling to drive filamentous tau-induced proinflammatory astrogliosis
    Peng Wang, Darrell E. Anderson, Yihong Ye · 2023 · Figshare
  68. Additional file 8 of PI3K-AKT activation resculpts integrin signaling to drive filamentous tau-induced proinflammatory astrogliosis
    Wang, Peng, Darrell E. Anderson, Yihong Ye · 2023 · Figshare
  69. Additional file 5 of PI3K-AKT activation resculpts integrin signaling to drive filamentous tau-induced proinflammatory astrogliosis
    Wang, Peng, Darrell E. Anderson, Yihong Ye · 2023 · Figshare
  70. Additional file 4 of PI3K-AKT activation resculpts integrin signaling to drive filamentous tau-induced proinflammatory astrogliosis
    Wang, Peng, Darrell E. Anderson, Yihong Ye · 2023 · Figshare
  71. Additional file 1 of PI3K-AKT activation resculpts integrin signaling to drive filamentous tau-induced proinflammatory astrogliosis
    Wang, Peng, Darrell E. Anderson, Yihong Ye · 2023 · Figshare
  72. Additional file 3 of PI3K-AKT activation resculpts integrin signaling to drive filamentous tau-induced proinflammatory astrogliosis
    Wang, Peng, Darrell E. Anderson, Yihong Ye · 2023 · Figshare
  73. Additional file 7 of PI3K-AKT activation resculpts integrin signaling to drive filamentous tau-induced proinflammatory astrogliosis
    Wang, Peng, Darrell E. Anderson, Yihong Ye · 2023 · Figshare
  74. Therapeutic Effect of Padina arborescens Extract on a Cell System Model for Parkinson’s Disease
    Dong Hwan Ho, Hye‐Jung Kim, Daleum Nam, Mi Kyoung Seo, Sung Woo Park, Dong‐Kyu Kim, Ilhong Son · 2024 · NeuroSci
  75. Deep brain stimulation using animal models of Parkinson's disease
    Amena S. El-Feky, Fatma M. Ali, Fatima Mohamed Abbas, Hend H. Mohamed · 2024 · Elsevier eBooks
  76. The interplay between CB 2 and NMDA receptors in Parkinson’s disease
    Jaume Lillo, Iu Raïch, Joan Biel Rebassa, Toni Capó, Pau Badia, Gemma Navarro, Irene Reyes‐Resina · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  77. Design and Development of Natural-Product-Derived Nanoassemblies and Their Interactions with Alpha Synuclein
    Ipsita A. Banerjee, Amrita Das, Mary A. Biggs, Chau Anh N. Phan, Liana R. Cutter, Alexandra R. Ren · 2025 · Biomimetics
  78. Heterodimers of Toll-like receptors (TLR) in the pathogenesis of systemic inflammation (Review article)
    И. Р. Прохоренко, Косякова Нинель Ивановна, Sergay Grachev · 2025 · Бюллетень Восточно-Сибирского научного центра Сибирского отделения Российской академии медицинских наук
  79. Multiomic profiling reveals aberrant immunomodulatory signature in β-propeller protein-associated neurodegeneration patient iPSC-derived microglia
    Gamze Özata, Rachel M. Wise, Aida Cardona‐Alberich, Naiyareen Fareeza Mayeen, Stephan A. Müller, Stefan F. Lichtenthaler, Luigi Zecca, Lena F. Burbulla · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  80. The compounding roles of gut-immune-brain axis and COVID19 in manifestation of idiopathic Parkinson’s disease
    Ankita Das, Vani Vivek, Palok Aich · 2025 · Discover Immunity.
  81. Single nuclear RNA sequencing shows altered microglial and astrocytic functions in post-mortem Parkinson’s disease tissue
    Indra Roy, Michael Fiorini, Rhalena A. Thomas, Georgina Jiménez Ambriz, Sali M.K. Farhan, Valerio E. C. Piscopo, Thomas M. Durcan · 2026 · BMC Genomic Data
  82. Diverse Effects of Various Toll-Like Receptor 2 Ligands on Neuronal Activity and Cell Death
    Futa Sato, Satoshi Hachimura · 2025 · Cellular and Molecular Neurobiology
  83. Design of a Multi‐Epitope Vaccine Targeting α‐Synuclein for Parkinson's Disease Using Immunoinformatics Tools
    Tatiane Batista dos Santos, Helena de Almeida Cerqueira Kodel, Geniana da Silva Gomes, Tatiane de Oliveira Xavier Machado, Dalton Ferreira Matos, Rafael J. Borges, Daniela Droppa‐Almeida, Margarete Zanardo Gomes · 2025 · Peptide Science
  84. Additional file 7 of MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
    Wallach, Thomas, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Christina Krüger, Paul Dembny et al. · 2021 · Figshare
  85. Additional file 3 of Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson’s disease
    Zhang, Ya-Nan, Fan, Jing-Kai, Gu, Li, Yang, Hui-Min, Zhan, Shu-Qin, Zhang, Hong · 2021 · Figshare
  86. Additional file 2 of Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson’s disease
    Zhang, Ya-Nan, Fan, Jing-Kai, Gu, Li, Yang, Hui-Min, Zhan, Shu-Qin, Zhang, Hong · 2021 · Figshare
  87. Additional file 2 of Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials
    Park, Jong Mi, Lee, Sang Chul, Chorom Ham, Yong Wook Kim · 2024 · Figshare
  88. Additional file 2 of p38-TFEB pathways promote microglia activation through inhibiting CMA-mediated NLRP3 degradation in Parkinson's disease
    Chen, Jialong, Mao, Kanmin, Yu, Honglin, Wen, Yue, She, Hua, Zhang, He, Liu, Linhua, Mingque Li, Li, Wenjun, Zou, Fei · 2021 · Figshare
  89. Additional file 1 of MLKL deficiency alleviates neuroinflammation and motor deficits in the α-synuclein transgenic mouse model of Parkinson’s disease
    Geng, Lu, Wenqing Gao, Hexige Saiyin, Li, Yuanyuan, Zeng, Yu, Zhang, Zhifei, Li, Xue, Liu, Zuolong, Qiang Gao, An, Ping et al. · 2023 · Figshare
  90. Additional file 1 of Parkinson’s disease-derived α-synuclein assemblies combined with chronic-type inflammatory cues promote a neurotoxic microglial phenotype
    Cansu Yildirim-Balatan, Alexis Fenyi, Pierre Besnault, Gomez, Lina, Julia Elisa Sepulveda-Diaz, Patrick Pierre Michel, Melki, Ronald, Stéphane Hunot · 2024 · Figshare
  91. Additional file 1 of Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials
    Park, Jong Mi, Lee, Sang Chul, Chorom Ham, Yong Wook Kim · 2024 · Figshare
  92. Additional file 5 of MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
    Wallach, Thomas, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Krüger, Christina, Paul Dembny et al. · 2021 · Figshare
  93. Additional file 2 of MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
    Wallach, Thomas, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Krüger, Christina, Paul Dembny et al. · 2021 · Figshare
  94. Additional file 6 of PI3K-AKT activation resculpts integrin signaling to drive filamentous tau-induced proinflammatory astrogliosis
    Wang, Peng, Darrell E. Anderson, Yihong Ye · 2023 · Figshare
  95. Additional file 2 of Neuroinflammation and protein pathology in Parkinson’s disease dementia
    Antonina Kouli, Camacho, Marta, Allinson, Kieren, Caroline H. Williams‐Gray · 2020 · Figshare
  96. Additional file 1 of Aging exacerbates the brain inflammatory micro-environment contributing to α-synuclein pathology and functional deficits in a mouse model of DLB/PD
    Michiyo Iba, McDevitt, Ross A., Changyoun Kim, Roshni Roy, Dimitra Sarantopoulou, Ella Tommer, Byron Siegars, Michelle A. Sallin, Somin Kwon, Jyoti Misra Sen et al. · 2022 · Figshare
  97. Additional file 3 of Effect of probiotic supplementation on gastrointestinal motility, inflammation, motor, non-motor symptoms and mental health in Parkinson’s disease: a meta-analysis of randomized controlled trials
    Park, Jong Mi, Lee, Sang Chul, Chorom Ham, Yong Wook Kim · 2024 · Figshare
  98. Additional file 3 of MicroRNA-100-5p and microRNA-298-5p released from apoptotic cortical neurons are endogenous Toll-like receptor 7/8 ligands that contribute to neurodegeneration
    Wallach, Thomas, Zoé J. Mossmann, Michal Szczepek, Max Wetzel, Rui S. R. Machado, Martin Raden, Milad Miladi, Gunnar Kleinau, Krüger, Christina, Paul Dembny et al. · 2021 · Figshare
  99. Additional file 1 of Neuroinflammation and protein pathology in Parkinson’s disease dementia
    Antonina Kouli, Marta Camacho, Allinson, Kieren, Caroline H. Williams‐Gray · 2020 · Figshare
  100. Additional file 1 of Metabotropic glutamate receptor 5 inhibits α-synuclein-induced microglia inflammation to protect from neurotoxicity in Parkinson’s disease
    Zhang, Ya-Nan, Fan, Jing-Kai, Gu, Li, Yang, Hui-Min, Shuqin Zhan, Zhang, Hong · 2021 · Figshare